echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Academic Express is heavy!

    Academic Express is heavy!

    • Last Update: 2022-09-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The international multi-center randomized controlled study DIRECT-SAFE, which was carried out in cooperation with China, Australia and other countries, was published online in The Lancet (Impact Factor IF=202.




    Research Introduction


    DIRECT-SAFE is an international, multicenter, prospective, randomized, open-label, endpoint-blinded trial (NCT03494920)



    The purpose of this study was to verify whether the clinical outcome of direct thrombectomy within 4.




    RESULTS: 295 patients were randomly assigned to either direct thrombectomy (n=148) or bridging therapy (n=147)




    Based on the results of the DIRECT-SAFE study, no noninferiority of direct thrombectomy was found compared with bridging therapy





    The DIRECT-SAFE study provides evidence to support bridging therapy
    .

    Although bridging therapy is recommended by default in the guidelines, based on all available clinical research evidence, specific patients with potential increased risk of intravenous thrombolysis, including late time windows or large infarct volumes, and direct travel can quickly provide For patients in hospitals where emergency endovascular thrombectomy is performed, direct mechanical thrombectomy can be considered
    .

    So far, six RCT studies of bridging therapy (DIRECT-MT, DEVT, SKIP, MR CLEAN-NO IV, DIRECT-SAFE, SWIFT DIRECT) have published results, and further meta-analysis (Improving Reperfusion strategies in Ischemic Stroke, IRIS) will Provides subgroups more likely to benefit
    .
    Author: Professor Huo Xiaochuan of Beijing Tiantan Hospital Wen Yuan: "Neural Intervention Online"


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.